Evaluating ArtiBest for treating knee osteoarthritis
Official title: Intra Articular Hyaluronic Acid (ArtiBest ® ) for Knee Osteoarthritis: A Post-market, Open Label, Long Term Study
Run by Maxigen Biotech Inc. · NCT06994546 · Data updated 2026-11-12
This study is testing if a new knee injection called ArtiBest can help people aged 35 to 85 with knee osteoarthritis feel less pain and move better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 35 Years to 85 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Maxigen Biotech Inc. Industry-sponsored |
| Locations | 1 site (Kaohsiung City) |
| Status | Recruiting |
| Started | March 11, 2025 |
| Main results expected | November 30, 2025 |
| Study ends | April 30, 2026 |
| Registry record updated | May 29, 2025 |
| Trial ID | NCT06994546 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 35 to 85 with mild to moderate knee osteoarthritis who have not adequately responded to conservative treatments.
✕Probably not a fit
Patients with severe knee osteoarthritis, infections at the injection site, or known hypersensitivity to hyaluronate may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to assess the effectiveness and safety of ArtiBest, an intra-articular injection containing sodium hyaluronate, for patients with knee osteoarthritis. Participants aged 35 to 85 with mild to moderate knee OA will receive a single injection and will be followed up at 4, 12, and 26 weeks to evaluate changes in pain scores and overall joint function. The study will measure various outcomes, including pain relief and patient satisfaction, using established scoring systems. Statistical analyses will be performed to determine the significance of the results.
Why it matters
Potential benefit: If successful, this treatment could provide significant pain relief and improved joint function for patients suffering from knee osteoarthritis.
How similar studies have gone: Previous studies have shown positive outcomes with similar hyaluronic acid injections for knee osteoarthritis, suggesting potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age from 35 to 85 years. * Subject with x ray imaging evidence of knee OA as Kellgren Lawrence grade = 2 or 3 within 1 month at screening. * Subject diagnosed with mild to moderate knee OA, particularly in patients who failed to respond adequately to conservative nonpharmacologic therapies or analgesics. * Subject with a 100 mm VAS resting pain score ≥ 30 mm in the studied knee at both the screening and treatment visit (screening visit and treatment visit can be on the same day) * Able and willing to comply with all study visits and procedures. * Willin g and capable of providing written informed consent. Exclusion Criteria: * Subjects with known hypersensitivity to hyaluronate. * Subjects with infections or skin diseases in the area of the injection site. * Pregnancy or breast feeding woman. * Joining other interventional trial s within 3 months prior to injecting this study product * Subject receive an intra articular (IA) injection of Hyaluronic Acid (HA) and/or steroid in target knee within 6 months prior to the trial * Subjects with rheumatoid arthritis * Any surgery to the target knee within the 12 months prior to the trial, or surgery to the contralateral knee or other weight bearing joint if it will interfere with knee assessments
Where it's running
-
Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, Taiwan Recruiting
Study contacts
- Study coordinator: Chen
- Email: lirong.chen@mbi.com.tw
- Phone: +88633287222
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
NPT Feasibility in Knee Osteoarthritis
This study tests whether NRPT can be safely given to adults with knee osteoarthritis and whether it shows early signals of benefit.
-
Aquatic exercise for knee osteoarthritis and central sensitization
A water-based exercise program is being tested to see if it helps people aged 40–65 with knee osteoarthritis who also have central sensitization.
-
Gender-based test of a graded weight-bearing physiotherapy for knee osteoarthritis
We’re testing a 6-week, sensory-modulated graded weight-bearing physiotherapy to see if outcomes differ between men and women with knee osteoarthritis.
-
Does implant type affect knee alignment when using KUNWU robotic surgery
This trial tests whether two knee implants (Attune vs Persona) used with the KUNWU robotic system result in more accurate knee alignment after total knee replacement.
-
Outpatient physiotherapy vs. mHealth exercise and self-management for knee osteoarthritis
This study tests whether a mobile app–guided, self-managed knee OA exercise program is as good as traditional hospital-based therapy for improving walking speed in adults with knee OA.
-
Digital Rehab Program for knee OA using multisensory gear and digital twin tech
A digital rehabilitation program with a smart knee brace and real-time feedback is tested to help adults with knee OA improve movement and function at home.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.